Press Releases

Nonin Medical Appoints Todd Austin as new Chief Executive Officer

November 18, 2025

New CEO Brings Strong Track Record Driving Strategic Growth in Respiratory Diagnostic and Medical Technology Companies

 

MINNEAPOLIS, MN, November 18, 2025 — Nonin Medical, a global leader in noninvasive medical monitoring solutions, today announced that its Board of Directors has appointed medical device industry leader Todd Austin as the company’s next Chief Executive Officer.

Austin is a seasoned medical technology executive recognized for driving strategic growth in respiratory diagnostics and medical technology companies. He brings extensive global leadership experience across strategic planning and execution, business development, external partnerships, product portfolio management, marketing, and clinical operations—combined with a proven ability to develop and advance effective business strategies that deliver meaningful results.

“Todd’s deep expertise in respiratory diagnostics and proven record of strategic leadership make him the ideal person to guide Nonin into its next phase of growth,” said Phil Isaacson, Executive Chairman, Board of Directors at Nonin Medical. “His passion for innovation in the respiratory medical device industry and commitment to advancing patient outcomes align perfectly with Nonin’s mission and values.”

Advances in medical technology continue to play a critical role in the healthcare industry. Nonin Medical remains dedicated to delivering dependable noninvasive monitoring solutions designed to support and empower healthcare professionals and patients around the world. The company looks forward to working closely with Austin as he leads Nonin in expanding our global impact and strengthening partnerships across the healthcare ecosystem.

“Throughout my 30+ years as a Respiratory Therapist, I’ve trusted and relied on Nonin’s products and technology across nearly every care setting — from bedside and critical care to transport, sleep and cardiopulmonary diagnostics, remote monitoring, and device integration,” said Austin. “Nonin has always stood for quality, reliability, and innovation, values that have guided my own career.”

Prior to joining Nonin Medical, Austin served as President and CEO of MGC Diagnostics, a subsidiary of CAIRE Inc. and Niterra. Prior to that, he held the role of Executive Vice President, Global Marketing, Engineering, and Corporate Strategy at MGC Diagnostics. His career also includes key leadership roles at Angeion, CareFusion, NDD, VIASYS Healthcare, and SensorMedics. In addition to his extensive industry background, Austin is a Registered Respiratory Therapist (RRT), Registered Pulmonary Function Technologist (RPFT), and Neonatal-Pediatric Specialist (NPS).

About Nonin Medical

Since 1986, Nonin Medical has developed reliable, high-performing technologies and manufactured innovative durable noninvasive patient monitoring devices for healthcare professionals, caregivers, and patients. Nonin pulse oximeters, cerebral and tissue oximeters, sensors, and software deliver dependable performance day after day—even in challenging environments. To learn more, visit nonin.com.

For more information, please contact:

Elizabeth Reddall, Nonin Medical
elizabeth.reddall@nonin.com